Page last updated: 2024-10-22

aminoglutethimide and Hypokalemia

aminoglutethimide has been researched along with Hypokalemia in 2 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harinck, HI1
van Brummelen, P1
Van Seters, AP1
Moolenaar, AJ1
Rodríguez, JA1

Other Studies

2 other studies available for aminoglutethimide and Hypokalemia

ArticleYear
Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
    Clinical endocrinology, 1984, Volume: 21, Issue:5

    Topics: Adrenocorticotropic Hormone; Adult; Alkalosis; Amiloride; Aminoglutethimide; Dexamethasone; Drug The

1984
[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Revista medica de Chile, 2000, Volume: 128, Issue:1

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adolescent; Aminoglutethimide; Blood Pressure; Body Hei

2000